Form 4: Artivion CEO James Mackin Executes Stock Transactions Under 10b5-1 Plan

Artivion's CEO, James Mackin, reports transactions involving common stock and stock options, including acquisitions, disposals, and exercises, under a pre-arranged 10b5-1 trading plan.

Summary

• James Mackin, the President and CEO of Artivion, Inc., filed a Form 4 detailing changes in beneficial ownership of the company's securities.
• On March 6, 2025, Mackin acquired 115,701 shares of common stock related to performance stock units granted on February 23, 2024, at a price of $0.
• He also sold 17,739 shares of common stock at $24.8044 per share to cover tax withholding obligations.
• Additionally, Mackin exercised stock options for 75,615 shares at an exercise price of $21.55 and sold 70,700 shares at a weighted average price of $24.7644 (ranging from $24.40 to $25.10).
• These transactions were executed under a 10b5-1 trading plan adopted on August 30, 2024.
• Following these transactions, Mackin beneficially owns 865,283 shares of Artivion common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transactions are part of a pre-planned trading strategy and include both acquisitions and sales. The sales to cover tax obligations are not necessarily indicative of a negative outlook.

Positives

• The acquisition of shares through performance stock units indicates confidence in the company's future performance.
• The use of a 10b5-1 trading plan provides transparency and avoids concerns about insider trading.

Negatives

• The sale of shares, even for tax obligations, could be perceived negatively by some investors.

Risks

• Executive stock sales, even under a 10b5-1 plan, can sometimes create short-term price volatility.
• Changes in executive ownership could signal shifts in management's long-term outlook, although this is less likely given the structured nature of the trading plan.

Future Outlook

The remaining performance stock units will vest on February 23, 2026, and February 23, 2027, assuming continued employment.

Industry Context

Executive stock transactions are common and closely monitored, especially in publicly traded companies. The use of 10b5-1 plans is a standard practice to ensure compliance with insider trading regulations.

Comparison to Industry Standards

• Executive compensation packages often include stock options and performance-based equity awards to align management's interests with those of shareholders.
• Companies like Medtronic and Abbott also utilize similar equity-based compensation strategies for their executives.
• The vesting schedules and trading plans are generally consistent with industry norms for executive compensation.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the potential for short-term price fluctuations.
• Employees may view the vesting of performance stock units as a positive sign of company performance.

Key Dates